Cetuximab (Cet) is a human/murine chimeric monoclonal antibody of EGFR with an immunoglobulin G1 Fc isotype7 that was treated in the metastatic CRC with the EGFR expression8. The gene discussed is EGFR; the disease is colorectal carcinoma.